Democritus University of Thrace (DUTH)
Η πειραματική διερεύνηση της συμβολής της λεπτίνης στην νεοαγγειογένεση: πειραματική μελέτη
Abstract
dc:descriptionLeptin, the product of the ob gene, is a non-glucosylated, 146 amino acid residue polypeptide that is produced and secreted by the adipocytes. Leptin plays a pivotal role in the regulation of body weight by controlling food intake, energy expenditure and sympathetic nervous system activity. Overwhelming evidence suggested a role for leptin as a multipotent cytokine implicated in the physiology of the digestive tract, reproductive function, haemopoesis, systemic neuroendocrine response and angiogenesis. Aim: The aim of this study was to investigate the angiogenic effect of leptin in vivo. Materials and methods: The disc angiogenesis system (DAS) was constructed as described previously and the disks were implanted subcutaneously in the back of 130 adult Wistar rats, in groups of 5 animals each. In the study group the disks contained as an angiogenic factor recombinant human leptin in concentrations of 25, 50, 100 and 250 ng/ml, respectively. In the negative control group leptin was replaced by normal saline. In order to study the specificity of the angiogenic effect of leptin, a specific anti-leptin antibody was used to inhibit the function of leptin with the implanted disks containing human recombinant leptin in concentrations of 25, 50, 100 and 250 ng/ml combined with 37.5, 75, 150 and 375 ng/ml of anti-leptin antibody, respectively. The discs were removed at 7 and 14 days after implantation, fixed in 10% formalin, embedded in paraffin and 5 μm thick planar sections were cut for immunohistochemistry and histological evaluation. Qualitative assessment of angiogenesis was performed on haematoxylin-eosin stained slides whereas quantitative assessment of angiogenesis was performed after immunohistochemical staining with an anti-CD34 antibody. Results: The number of new blood vessels in discs containing different leptin concentrations was significantly higher compared with control discs and increased proportionally with increasing concentrations of leptin and peaked at 100 ng/ml. This finding was observed at both time points (7 and 14 days after disc implantation). There was no significant difference between the leptin-induced number of blood vessels at 7 and 14 days for any concentration. Specific blocking of leptin abolished completely its angiogenic effect. The number of new blood vessels in discs containing different VEGF165 concentrations was significantly higher compared with control discs and increased proportionally with increasing concentrations of VEGF165 with a peak at 100 ng/ml. This finding was observed at both time points (7 and 14 days after disc implantation). The number of VEGF165-induced blood vessels at 14 days was significantly higher compared with the number of blood vessels at 7 days for all concentrations used. The leptin-induced number of new blood vessels at 7 days was significantly higher compared with the VEGF165-induced number of new blood vessels and was observed at all concentrations used. In contrast, there was no significant difference between leptin- and VEGF165-induced numbers of new blood vessels at the 14-day time point. Conclusions: It is concluded that leptin has an angiogenic effect in vivo. This effect is specific, dose- and time- dependent, and comparable with the angiogenic effect of VEGF165 but is evident earlier compared with the angiogenic effect of VEGF165.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Αναγνωστούλης, Σταύρος
- Anagnostoulis, Stavros
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17568